<?xml version="1.0" encoding="UTF-8"?>
<table-wrap id="T0001" orientation="portrait" position="float">
 <label>Table 1</label>
 <caption>
  <p>Grouping of antitubercular drugs for design of regimens for treatment of drug-resistant tuberculosis</p>
 </caption>
 <table frame="hsides" rules="groups">
  <thead>
   <tr>
    <th colspan="2" rowspan="1">WHO Guidelines 2014
     <xref rid="CIT0056" ref-type="bibr">56</xref>
    </th>
    <th colspan="2" rowspan="1">WHO Guidelines 2016
     <xref rid="CIT0051" ref-type="bibr">51</xref>
    </th>
    <th colspan="2" rowspan="1">WHO Guidelines 2019
     <xref rid="CIT0001" ref-type="bibr">1</xref>
    </th>
   </tr>
   <tr>
    <th rowspan="1" colspan="1">Group</th>
    <th rowspan="1" colspan="1">Anti-TB Drugs</th>
    <th rowspan="1" colspan="1">Group</th>
    <th rowspan="1" colspan="1">Anti-TB drugs</th>
    <th rowspan="1" colspan="1">Group</th>
    <th rowspan="1" colspan="1">Anti-TB Drugs</th>
   </tr>
  </thead>
  <tbody>
   <tr>
    <td rowspan="1" colspan="1">
     <bold>Group 1</bold>
     <break/>First-line oral agents
    </td>
    <td rowspan="1" colspan="1">Z
     <break/>E
     <break/>Rfb
    </td>
    <td rowspan="1" colspan="1">
     <bold>Group A</bold>
     <break/>Fluoroquinolones
    </td>
    <td rowspan="1" colspan="1">Lfx
     <break/>Mfx
     <break/>Gfx
    </td>
    <td rowspan="1" colspan="1">
     <bold>Group A</bold>
     <break/>Include all three drugs in regimen, unless contraindicated
    </td>
    <td rowspan="1" colspan="1">Lfx or Mfx
     <break/>Bdq
     <break/>Lzd
    </td>
   </tr>
   <tr>
    <td rowspan="1" colspan="1">
     <bold>Group 2</bold>
     <break/>Injectable agents
    </td>
    <td rowspan="1" colspan="1">S
     <break/>Km
     <break/>Am
     <break/>Cm
    </td>
    <td rowspan="1" colspan="1">
     <bold>Group B</bold>
     <break/>Second-line injectable agents
    </td>
    <td rowspan="1" colspan="1">Am
     <break/>Cm
     <break/>Km
    </td>
    <td rowspan="1" colspan="1">
     <bold>Group B</bold>
     <break/>Addition of one or both drugs
    </td>
    <td rowspan="1" colspan="1">Cfz
     <break/>Cs or Trd
    </td>
   </tr>
   <tr>
    <td rowspan="1" colspan="1">
     <bold>Group 3</bold>
     <break/>Fluoroquinolones
    </td>
    <td rowspan="1" colspan="1">Lfx
     <break/>Mfx
     <break/>Ofx
    </td>
    <td rowspan="1" colspan="1">
     <bold>Group C</bold>
     <break/>Other core second-line agents
    </td>
    <td rowspan="1" colspan="1">Eto
     <break/>Pto
     <break/>Cs
     <break/>Trd
     <break/>Lzd
     <break/>Cfz
    </td>
    <td rowspan="3" colspan="1">
     <bold>Group C</bold>
     <break/>Addition of these drugs to complete regimen when drugs from abovementioned groups cannot be used
    </td>
    <td rowspan="3" colspan="1">E
     <break/>Dlm
     <break/>Z
     <break/>Ipm-Cln or Mpm
     <break/>Am or S
     <break/>Eto or Pto
     <break/>PAS
    </td>
   </tr>
   <tr>
    <td rowspan="1" colspan="1">
     <bold>Group 4</bold>
     <break/>Oral bacteriostatic second-line agents
    </td>
    <td rowspan="1" colspan="1">Eto
     <break/>Pto
     <break/>Cs
     <break/>Trd
     <break/>PAS
    </td>
    <td rowspan="2" colspan="1">
     <bold>Group D</bold>
     <break/>Add-on agents
    </td>
    <td rowspan="1" colspan="1">D1
     <break/>Z
     <break/>E
     <break/>High-dose H
    </td>
   </tr>
   <tr>
    <td rowspan="1" colspan="1">
     <bold>Group 5</bold>
     <break/>Drugs with unclear efficacy or unclear role in MDR-TB treatment, not recommended by WHO for routine use in MDR-TB patients
    </td>
    <td rowspan="1" colspan="1">Bdq
     <break/>Dlm
     <break/>Lzd
     <break/>Cfz
     <break/>Amx-Clv
     <break/>Ipm-Cln
     <break/>Mpm
     <break/>High-dose H
     <break/>T
     <break/>Clr
    </td>
    <td rowspan="1" colspan="1">D2
     <break/>Bdq
     <break/>Dlm
    </td>
   </tr>
   <tr>
    <td rowspan="1" colspan="1">D3
     <break/>PAS
     <break/>Ipm-Cln
     <break/>Mpm
     <break/>Amx-Clv
     <break/>T
    </td>
   </tr>
  </tbody>
 </table>
 <table-wrap-foot>
  <fn>
   <p>
    <bold>Abbreviations:</bold> H, isoniazid; R, rifampicin; E, ethambutol; Z, pyrazinamide; Rfb, rifabutin; S, streptomycin; Km, kanamycin; Am, amikacin; Cm, capreomycin; Ofx, ofloxacin; Lfx, levofloxacin; Mfx, moxifloxacin; Gfx, gatifloxacin; Eto, ethionamide; Pto, protionamide; PAS, P-aminosalicylic acid; Cs, cycloserine; Cfz, clofazimine; Lzd, linezolid; Clr, clarithromycin; Bdq, bedaquiline; Dlm, delamanid; Ipm-Cln, imipenem–cilastatin; Mpm, meropenem; Amx-Clv, amoxycillin–clavulanate; T, thioacetazone.
   </p>
  </fn>
 </table-wrap-foot>
</table-wrap>
